February 18, 2026 - 08:16

Live Nation Entertainment, the global powerhouse behind countless concerts and live events, has confirmed its participation in a premier financial gathering. The company announced that President and Chief Financial Officer Joe Berchtold is scheduled to present at the Morgan Stanley Technology, Media & Telecom Conference in 2026.
This high-profile appearance will place Live Nation's executive leadership before a key audience of investors and industry analysts. The conference is a significant forum for major corporations to share their strategic vision, operational updates, and financial outlook within the evolving tech and media landscape. Berchtold's presentation is expected to cover the company's performance, its adaptation to digital trends, and its growth strategy for the live entertainment sector.
The scheduled participation underscores Live Nation's continued focus on engaging with the investment community. It provides a platform to articulate the company's long-term trajectory and its role in shaping the future of live experiences. Further details regarding the exact date and time of the presentation will be released by the company at a later date.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...